Es gab 50 kürzliche Insider-Transaktionen für Sarepta Therapeutics, Inc. (SRPT), darunter 22 Käufe und 26 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $8.94M und die gesamten Insider-Verkäufe auf $1.65M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Mayo Stephen, Rodino-klapac Louise, Estepan Ian Michael. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — SRPT
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-12 |
Mayo Stephen |
Director |
Informierter Verkauf |
7,239 |
$17.02 |
$123.21K |
1,765 |
| 2026-03-11 |
Rodino-klapac Louise |
President, R&d and Tech Ops |
RSU-Steuereinbehalt |
948 |
$17.03 |
$16.14K |
225,323 |
| 2026-03-11 |
Estepan Ian Michael |
Chief Operating Officer |
RSU-Steuereinbehalt |
1,097 |
$17.03 |
$18.68K |
201,983 |
| 2026-03-11 |
Rothfuss Cristin |
EVP, General Counsel |
RSU-Steuereinbehalt |
974 |
$17.03 |
$16.59K |
137,544 |
| 2026-03-11 |
Wong Ryan Ho-yan |
Chief Financial Officer |
RSU-Steuereinbehalt |
256 |
$17.03 |
$4.36K |
135,064 |
| 2026-03-10 |
Wong Ryan Ho-yan |
Chief Financial Officer |
Unbekannt |
1,208 |
$99.69 |
$120.43K |
- |
| 2026-03-09 |
Rodino-klapac Louise |
President, R&d and Tech Ops |
RSU-Steuereinbehalt |
895 |
$16.95 |
$15.17K |
226,271 |
| 2026-03-09 |
Estepan Ian Michael |
Chief Operating Officer |
RSU-Steuereinbehalt |
583 |
$16.95 |
$9.88K |
203,080 |
| 2026-03-09 |
Rothfuss Cristin |
EVP, General Counsel |
RSU-Steuereinbehalt |
346 |
$16.95 |
$5.86K |
138,518 |
| 2026-03-09 |
Wong Ryan Ho-yan |
Chief Financial Officer |
RSU-Steuereinbehalt |
113 |
$16.95 |
$1.92K |
135,320 |
| 2026-03-02 |
Rodino-klapac Louise |
President, R&d and Tech Ops |
RSU-Steuereinbehalt |
767 |
$16.20 |
$12.43K |
227,670 |
| 2026-03-02 |
Estepan Ian Michael |
Chief Operating Officer |
RSU-Steuereinbehalt |
875 |
$16.20 |
$14.18K |
204,699 |
| 2026-03-02 |
Rothfuss Cristin |
EVP, General Counsel |
RSU-Steuereinbehalt |
408 |
$16.20 |
$6.61K |
139,348 |
| 2026-03-02 |
Wong Ryan Ho-yan |
Chief Financial Officer |
RSU-Steuereinbehalt |
450 |
$16.20 |
$7.29K |
135,595 |
| 2026-03-01 |
Rodino-klapac Louise |
President, R&d and Tech Ops |
Optionsausübung (Verkauf) |
8,125 |
- |
- |
- |
| 2026-03-01 |
Estepan Ian Michael |
Chief Operating Officer |
Optionsausübung (Verkauf) |
8,125 |
- |
- |
- |
| 2026-02-26 |
Estepan Ian Michael |
Chief Operating Officer |
Optionsausübung (Verkauf) |
5,381 |
$13.71 |
$73.77K |
- |
| 2026-02-25 |
Rodino-klapac Louise |
President, R&d and Tech Ops |
RSU-Zuteilung |
1,875 |
- |
- |
8,125 |
| 2026-02-25 |
Estepan Ian Michael |
Chief Operating Officer |
RSU-Zuteilung |
1,875 |
- |
- |
8,125 |
| 2026-01-29 |
Nicaise Claude |
Director |
Optionsausübung (Verkauf) |
10,500 |
$13.71 |
$143.96K |
- |
| 2026-01-27 |
Behrens M Kathleen |
Director |
Optionsausübung |
10,500 |
$13.71 |
$143.96K |
- |
| 2025-12-18 |
Chambers Michael Andrew |
Director |
Aktienrückgabe |
- |
$141.97 |
- |
- |
| 2025-12-16 |
Estepan Ian Michael |
Chief Operating Officer |
Informierter Verkauf |
13,187 |
$22.31 |
$294.2K |
193,300 |
| 2025-12-07 |
Ingram Douglas S |
Chief Executive Officer |
RSU-Zuteilung |
50,000 |
- |
- |
440,307 |
| 2025-12-01 |
Wong Ryan Ho-yan |
Chief Financial Officer |
RSU-Steuereinbehalt |
78 |
$20.96 |
$1.63K |
136,045 |
| 2025-11-28 |
Rothfuss Cristin |
EVP, General Counsel |
RSU-Steuereinbehalt |
229 |
$21.12 |
$4.84K |
139,756 |
| 2025-11-17 |
Rodino-klapac Louise |
President, R&d and Tech Ops |
RSU-Steuereinbehalt |
4,582 |
$18.42 |
$84.4K |
224,030 |
| 2025-09-03 |
Rodino-klapac Louise |
President, R&d and Tech Ops |
RSU-Zuteilung |
93,875 |
- |
- |
178,612 |
| 2025-09-03 |
Estepan Ian Michael |
Chief Operating Officer |
RSU-Zuteilung |
93,875 |
- |
- |
156,487 |
| 2025-09-03 |
Rothfuss Cristin |
EVP, General Counsel |
RSU-Zuteilung |
93,875 |
- |
- |
114,985 |
| 2025-09-03 |
Wong Ryan Ho-yan |
Chief Financial Officer |
RSU-Zuteilung |
93,875 |
- |
- |
111,203 |
| 2025-08-05 |
Rodino-klapac Louise |
President, R&d and Tech Ops |
RSU-Zuteilung |
6,250 |
- |
- |
6,250 |
| 2025-08-05 |
Estepan Ian Michael |
Chief Operating Officer |
RSU-Zuteilung |
6,250 |
- |
- |
6,250 |
| 2025-08-05 |
Arif Bilal |
Chief Tech Ops Officer |
RSU-Zuteilung |
6,250 |
- |
- |
6,250 |
| 2025-07-31 |
Wong Ryan Ho-yan |
Chief Financial Officer |
RSU-Steuereinbehalt |
327 |
$16.42 |
$5.37K |
17,328 |
| 2025-07-16 |
Wong Ryan Ho-yan |
Chief Financial Officer |
Unbekannt |
- |
- |
- |
17,655 |
| 2025-05-16 |
Barry Richard |
Director |
Optionsausübung (Verkauf) |
12,350 |
$32.63 |
$402.98K |
- |
| 2025-05-13 |
Barry Richard |
Director |
Optionsausübung (Verkauf) |
10,500 |
$13.71 |
$143.96K |
- |
| 2025-03-12 |
Nicaise Claude |
Director |
Optionsausübung (Verkauf) |
9,746 |
$25.18 |
$245.4K |
- |
| 2025-03-10 |
Behrens M Kathleen |
Director |
RSU-Zuteilung |
4,792 |
$99.69 |
$477.71K |
4,792 |
| 2025-03-10 |
Connelly Deirdre P |
Director |
RSU-Zuteilung |
4,792 |
$99.69 |
$477.71K |
4,792 |
| 2025-03-10 |
Wigzell Hans Lennart Rudolf |
Director |
RSU-Zuteilung |
4,792 |
$99.69 |
$477.71K |
4,792 |
| 2025-03-10 |
Barry Richard |
Director |
RSU-Zuteilung |
4,792 |
$99.69 |
$477.71K |
4,792 |
| 2025-03-10 |
Nicaise Claude |
Director |
RSU-Zuteilung |
4,792 |
$99.69 |
$477.71K |
20,557 |
| 2025-03-10 |
Boor Kathryn Jean |
Director |
RSU-Zuteilung |
4,792 |
$99.69 |
$477.71K |
4,792 |
| 2025-03-10 |
Rodino-klapac Louise |
Head of R&d, CSO |
RSU-Zuteilung |
16,644 |
$99.69 |
$1.66M |
16,644 |
| 2025-03-10 |
Estepan Ian Michael |
Chief Financial Officer |
RSU-Zuteilung |
16,644 |
$99.69 |
$1.66M |
16,644 |
| 2025-03-10 |
Mayo Stephen |
Director |
RSU-Zuteilung |
4,792 |
$99.69 |
$477.71K |
4,792 |
| 2025-03-10 |
Chambers Michael Andrew |
Director |
RSU-Zuteilung |
4,792 |
$99.69 |
$477.71K |
4,792 |
| 2025-03-10 |
Arif Bilal |
Chief Tech Ops Officer |
RSU-Zuteilung |
16,644 |
$99.69 |
$1.66M |
16,644 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
